BioCryst Pharmaceuticals Inc (BCRX) — Free Cash Flow Generation Index

Latest as of December 2025: 1.00x

BioCryst Pharmaceuticals Inc (BCRX) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $275.23 Million represents 1% of operating cash flow ($276.04 Million). Explore BioCryst Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$275.23 Million

USD

Operating Cash Flow

$276.04 Million

USD

Capital Expenditures

$802.00K

USD

BioCryst Pharmaceuticals Inc Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for BioCryst Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see BioCryst Pharmaceuticals Inc (BCRX) cash conversion ratio.

Annual Free Cash Flow Generation for BioCryst Pharmaceuticals Inc (2025–2025)

Year-by-year Free Cash Flow Generation Index for BioCryst Pharmaceuticals Inc. Check BioCryst Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	0.99x	$327.41 Million	$329.88 Million	$2.47 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).